Saturday 17 October 2026
Export PRGO’s income statement to Excel — free account
Perrigo Company plc
PRGO Healthcare Drug Manufacturers Specialty & Generic
Perrigo Company plc’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 2.75% from fiscal 2024. In the quarter to June 2026, revenue fell 3.17%, EPS grew 1,000.0%, free cash flow grew 18.4% and total debt fell 9.78%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
16.63
0.15
+0.91%
Follow PRGO
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 106.77 | 41.22 | 47.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
— | 9 | 6 | 6 | 4 | 7 | 4 | 6 | 4 | 4 |
Altman Z-Score |
0.68 | 1.86 | 1.02 | 1.10 | 1.01 | 1.12 | 0.79 | 0.78 | 0.74 | (0.08) |
P/S ratio |
2.35 | 2.58 | 1.13 | 1.82 | 1.49 | 1.26 | 1.06 | 0.96 | 0.81 | 0.45 |
Altman Z″-Score (non-manufacturers) |
(0.21) | 1.76 | 1.53 | 1.53 | 1.65 | 2.12 | 1.22 | 1.05 | 1.15 | (0.37) |
P/FCF ratio |
13.74 | 18.30 | 10.59 | 27.77 | 12.95 | 649.63 | 19.76 | 13.68 | 12.28 | 12.57 |
P/Operating CF |
60.11 | 58.84 | 27.48 | 78.50 | 55.13 | (49.31) | 25.47 | 21.50 | 11.30 | 10.99 |
Beneish M-Score |
(3.77) | (2.72) | (2.73) | (2.34) | (3.19) | (2.53) | (2.52) | (2.68) | (2.83) | (3.51) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 16 |
P/B ratio |
2.08 | 2.07 | 0.94 | 1.21 | 1.08 | 1.01 | 0.98 | 0.94 | 0.82 | 0.66 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 85.84 | 5,774.49 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.33 | 3.12 | 1.70 | 2.59 | 2.21 | 1.66 | 1.85 | 1.68 | 1.51 | 1.18 |
EV/EBITDA |
0.00 | 15.11 | 12.32 | 17.71 | 13.93 | 9.53 | 19.77 | 15.20 | 14.72 | 0.00 |
EV/Operating CF |
26.83 | 22.07 | 13.54 | 25.89 | 14.18 | 43.84 | 26.82 | 19.26 | 18.16 | 21.12 |
EV/FCF |
19.47 | 22.11 | 15.93 | 39.69 | 19.20 | 856.58 | 34.38 | 23.81 | 22.91 | 32.83 |
Quick Ratio |
0.98 | 1.26 | 1.06 | 1.20 | 0.89 | 1.59 | 1.17 | 0.94 | 1.15 | 1.13 |
Current Ratio |
1.53 | 1.96 | 1.89 | 2.04 | 2.27 | 2.43 | 2.44 | 1.79 | 2.38 | 2.76 |
Net Debt/EBITDA |
(3.30) | 2.61 | 4.13 | 5.32 | 4.53 | 2.30 | 8.41 | 6.47 | 6.83 | (4.01) |
Debt/Assets |
41.80% | 28.73% | 29.52% | 29.81% | 31.03% | 33.77% | 37.27% | 37.68% | 37.50% | 42.65% |
Debt/Equity |
0.97 | 0.54 | 0.57 | 0.58 | 0.63 | 0.68 | 0.85 | 0.85 | 0.84 | 1.24 |
Asset Turnover |
0.32 | 0.39 | 0.42 | 0.35 | 0.36 | 0.38 | 0.42 | 0.43 | 0.43 | 0.47 |
Operating CF/Net income |
(0.16) | 5.84 | 4.53 | 2.65 | (3.91) | (2.27) | (2.19) | (31.93) | (2.11) | (0.17) |
Capex/Depreciation |
0.57 | 0.00 | (0.21) | (0.34) | (0.43) | (0.48) | (0.20) | (0.21) | (0.22) | (0.25) |
Interest Coverage |
(9.23) | 3.56 | 1.85 | 1.49 | 2.08 | 3.28 | 0.51 | 0.87 | 0.60 | (6.91) |
| (49.96%) | 1.97% | 2.21% | 2.55% | (2.84%) | (1.28%) | (2.81%) | (0.26%) | (3.78%) | (39.29%) | |
| (24.16%) | 0.94% | 1.16% | 1.31% | (1.43%) | (0.63%) | (1.31%) | (0.12%) | (1.68%) | (15.68%) | |
ROIC |
(11.23%) | 4.23% | 1.77% | 1.24% | 1.93% | 3.77% | 0.59% | 1.17% | 0.96% | (11.60%) |
Return on Tangible Assets |
(218.19%) | 5.40% | 5.97% | 6.36% | (6.22%) | (2.20%) | (5.55%) | (0.59%) | (7.29%) | (53.12%) |
Average Days of Receivables |
81.29 | 83.45 | 82.78 | 117.26 | 52.99 | 57.58 | 57.16 | 57.98 | 53.61 | 52.59 |
Research and Development Expense of Revenue |
3.48% | 3.39% | 4.62% | 3.08% | 2.98% | 2.95% | 2.77% | 2.63% | 2.57% | 2.24% |
Selling, General and Administrative Expense of Revenue |
22.83% | 23.18% | 23.79% | 28.35% | 27.13% | 26.85% | 27.18% | 27.38% | 25.44% | 24.82% |
Intangible Assets out of Total Assets |
0.71 | 0.65 | 0.63 | 0.63 | 0.49 | 0.49 | 0.62 | 0.60 | 0.60 | 0.52 |
Share Based Compensation of Revenue |
0.44% | 0.89% | 0.80% | 1.35% | 1.43% | 1.45% | 1.23% | 1.48% | 1.47% | 1.28% |
Graham Net Nets |
(0.41) | (0.21) | (0.45) | (0.39) | (0.44) | (0.27) | (0.73) | (0.71) | (0.81) | (1.45) |
Graham Number |
0.00 | 28.63 | 29.50 | 32.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(29.67%) | 0.94% | 2.43% | 2.09% | (2.68%) | (0.87%) | (2.73%) | (0.30%) | (4.86%) | (73.85%) |
Free Cash Flow Yield |
7.28% | 5.47% | 9.44% | 3.60% | 7.72% | 0.15% | 5.06% | 7.31% | 8.14% | 7.96% |
Revenue per Share |
36.85 | 34.76 | 34.34 | 28.46 | 30.04 | 30.98 | 33.10 | 34.41 | 31.83 | 30.71 |
Operating CF per Share |
4.57 | 4.91 | 4.30 | 2.85 | 4.67 | 1.17 | 2.28 | 3.00 | 2.64 | 1.72 |
Capex per Share |
1.73 | (0.01) | (0.65) | (0.99) | (1.22) | (1.11) | (0.50) | (0.57) | (0.55) | (0.63) |
Free Cash Flow per Share |
6.30 | 4.90 | 3.66 | 1.86 | 3.45 | 0.06 | 1.78 | 2.42 | 2.09 | 1.09 |
Cash per Share |
4.34 | 4.77 | 4.00 | 2.61 | 4.64 | 13.96 | 4.47 | 5.55 | 4.07 | 3.84 |
Shareholders Equity per Share |
41.57 | 43.36 | 41.13 | 42.68 | 41.55 | 38.56 | 36.00 | 35.24 | 31.44 | 21.19 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
41.57 | 43.36 | 41.13 | 42.68 | 41.55 | 38.56 | 36.00 | 35.24 | 31.44 | 21.19 |
Free Cash Flow |
902.40 | 697.60 | 504.10 | 253.00 | 469.90 | 8.00 | 239.70 | 328.00 | 287.70 | 150.70 |
Working Capital |
969.00 | 1,383.60 | 1,364.80 | 1,394.80 | 1,751.50 | 2,272.00 | 1,606.30 | 1,246.60 | 1,437.70 | 1,784.50 |
Capital Expenditures |
247.50 | (1.30) | (88.90) | (134.80) | (166.30) | (148.30) | (67.60) | (77.50) | (75.20) | (87.80) |
Net Current Asset Value |
(5,107.20) | (2,638.60) | (2,413.10) | (2,766.70) | (2,699.80) | (1,414.10) | (3,455.30) | (3,208.30) | (2,846.40) | (2,802.30) |
EV/EBIT |
0.00 | 25.79 | 33.96 | 57.47 | 34.01 | 16.70 | 104.46 | 51.42 | 58.39 | 0.00 |
Capex to Sales |
(0.05) | 0.00 | 0.02 | 0.03 | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 |
Price to Operating Income |
0.00 | 21.34 | 22.58 | 40.22 | 22.95 | 12.66 | 60.02 | 29.55 | 31.29 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.50 | 0.51 | 0.50 | 0.43 | 0.44 | 0.36 | 0.36 | 0.39 | 0.36 | 0.39 |
Cash ROIC |
7.29% | 6.85% | 5.33% | 2.66% | 4.77% | 0.08% | 2.51% | 3.42% | 3.39% | 2.12% |
Accounts Receivable Turnover |
4.47 | 4.29 | 4.29 | 3.34 | 4.45 | 6.64 | 6.60 | 6.48 | 6.33 | 6.78 |
Accounts Payable Turnover |
6.28 | 6.44 | 6.27 | 4.90 | 5.34 | 6.31 | 6.32 | 5.86 | 5.82 | 5.69 |
Inventory Turnover |
3.81 | 3.70 | 3.44 | 2.64 | 2.56 | 2.62 | 2.76 | 2.60 | 2.55 | 2.47 |
Average Days of Payables |
53.32 | 55.39 | 59.77 | 77.94 | 63.56 | 55.13 | 65.45 | 58.60 | 63.85 | 62.78 |
Days of Inventory on Hand |
89.87 | 99.27 | 110.50 | 144.92 | 149.11 | 136.78 | 140.13 | 139.97 | 139.49 | 152.03 |
Average Receivables |
1,182.50 | 1,153.40 | 1,101.95 | 1,158.15 | 918.35 | 623.20 | 675.00 | 718.35 | 690.95 | 627.55 |
Average Payables |
513.75 | 460.95 | 462.55 | 497.55 | 485.90 | 431.40 | 474.25 | 507.50 | 486.45 | 484.85 |
Average Inventory |
846.85 | 800.95 | 842.45 | 922.65 | 1,013.35 | 1,039.80 | 1,085.25 | 1,145.60 | 1,111.35 | 1,115.40 |
Average Assets |
16,609.85 | 12,749.45 | 11,306.10 | 11,142.40 | 11,394.90 | 10,957.05 | 10,721.50 | 10,913.20 | 10,228.40 | 9,091.45 |
Average Common Equity |
8,032.20 | 6,064.10 | 5,919.35 | 5,736.10 | 5,729.60 | 5,403.40 | 4,996.90 | 4,805.00 | 4,543.65 | 3,627.45 |
Columns are period end dates